Evidence map›Paper›PMID 42392841›Full record

ArticleClinical genetics2026

Phenotypic Characterization of Five Children With PACS1-NDD: Longitudinal Insights Into Development, Behavior, and Brain.

Fiona Journal, Nada Kojovic, Kenza Latrèche, Stefania Solazzo, Marie Schaer

Abstract read
In one paragraph

Article in Clinical genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fiona JournalDepartment of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland.ORCID https://orcid.org/0009-0001-8269-3765
Nada KojovicDepartment of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland.ORCID https://orcid.org/0000-0003-0116-2485
Kenza LatrècheDepartment of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland.ORCID https://orcid.org/0000-0003-0264-4048
Stefania SolazzoDepartment of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Marie SchaerDepartment of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland.ORCID https://orcid.org/0000-0001-8479-6365

Funding

Fondation Pôle AutismeFondation privée des Hôpitaux Universitaires de GenèveNational Centre of Competence in Research (NCCR) Synapsy 51NF40-185897Swiss National Science Foundation (SNSF) 163859Swiss National Science Foundation (SNSF) 190084Swiss National Science Foundation (SNSF) 202235Swiss National Science Foundation (SNSF) 212653
6 · The paper itself

Abstract

PACS1 neurodevelopmental disorder (PACS1-NDD), also known as Schuurs-Hoeijmakers syndrome, is a rare genetic condition caused by a recurrent de novo mutation in the PACS1 gene. Autistic traits have been reported in PACS1-NDD, but systematic longitudinal assessments are lacking. We followed five children (3 females) with genetically confirmed PACS1-NDD, aged 1.4-6.2 years at entry, over 2-3.5 years (29 assessments). Measures included standardized behavioral and cognitive assessments, eye-tracking, and structural MRI. Data were compared to 357 autistic and 123 typically developing children from a longitudinal cohort. Children with PACS1-NDD showed global developmental delays with heterogeneous trajectories. Adaptive and communication profiles overlapped with autistic children, while motor impairments were more pronounced. Vocabulary and grammar were delayed, but pragmatic skills were relatively preserved. All children with PACS1-NDD exhibited autistic traits with elevated restricted and repetitive behaviors and milder social-communication difficulties. ADHD symptoms were subthreshold and predominantly inattentive. Eye-tracking revealed preserved social interest but reduced gaze typicality in naturalistic contexts. MRI showed globally reduced gray and white matter volumes. These findings provide the first longitudinal, multimodal characterization of PACS1-NDD, informing clinical care and targeted outcome measures for therapeutic trials, and highlighting the need for larger studies to validate and extend these findings.

Indexed as

BrainNeurodevelopmental DisordersVesicular Transport ProteinsAutistic DisorderChildChild, PreschoolFemaleHumansInfantLongitudinal StudiesMagnetic Resonance ImagingMaleMutationPhenotypePACS1 protein, humanVesicular Transport ProteinsADHDASDdevelopmental trajectorieseye‐trackingMRIPACS1 neurodevelopmental disorderSchuurs–Hoeijmakers syndrome

Identifiers

PMID42392841
PMCPMC13432291

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.